Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national
national blog main
national top stories
new york top stories
3
×
novartis
roche
3
×
san francisco top stories
amgen
biogen
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
diagnostics
drug prices
gene therapy
immunotherapy
indiana blog main
indiana top stories
medicare
merck
new york blog main
pfizer
president trump
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
seattle blog main
seattle top stories
sickle cell disease
spark therapeutics
texas blog main
texas top stories
What
drug
patients
3
×
bio
new
roundup
acquisitions
advantages
albert
approved
atrophy
bar
biggest
bourla
brings
ceo
company
crispr
daily
evrysdi
expect
fda
friday
future
gamble
green
home
imports
intended
lights
liquid
maker
maps
market
measured
medco’s
medicine
mover
muscular
oral
payers
Language
unset
unknown
Current search:
roche
×
patients
×
" new york top stories "
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More